This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bernard OA, Busson-Le Coniat M, Ballerini P, Mauchauffé M, Della Valle V, Monni R et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 2002; 15: 1495–1504.
Berger R, Dastugue N, Busson M, van den Akker J, Pérot C, Ballerini P, et al., on behalf of the Groupe Français e Cytogénétique Hématologique (GFCH). t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukaemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH). Leukemia 2003; 17: 1851–1857.
Ballerini P, Blaise A, Busson-Le Coniat M, Su XY, Zucman-Rossi J, Adam M et al. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Leukemia 2002; 100: 991–996.
Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75–87.
Cavé H, Suciu S, Preudhomme C, Poppe B, Robert A, Uyttebroeck A, et al., for the EORTC-CLG. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood 2004; 103: 442–450.
Mauvieux L, Leymarie V, Helias C, Perrusson N, Falkenrodt A, Lioure B et al. High incidence of Hox11L2 expression in children with T-ALL. Leukemia 2002; 16: 2417–2422.
Barber KE, Martineau M, Harewood L, Stewart M, Cameron E, Strefford JC et al. Amplification of the ABL gene in T-cell acute lymphoblastic leukemia. Leukemia 2004; 18: 1153–1156.
Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R et al. Fusion of NUP214 to BL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004; 36: 1084–1089.
Le Coniat M, Romana SP, Berger R . Partial chromosome 21 amplification in a child with acute lymphoblastic leukemia. Genes Chromosomes Cancer 1995; 14: 204–209.
Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase reaction (RQ-PCR) – a Europe against cancer program. Leukemia 2003; 17: 2474–2486.
Bièche I, Onody P, Laurendeau I, Olivi M, Lidereau R, Vidaud M . Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem 1999; 45: 1148–1156.
Carroll SM, DeRose ML, Gaudray P, Moore CM, Needham-Vendevanter DR, von Hoff DD et al. Double minute can be produced from precursors derived from a chromosomal deletion. Mol Cell Biol 1988; 8: 1525–1533.
Carroll SM, Gaudray P, DeRose ML, Emery JF, Meinkoth JL, Nakkim E et al. Characterization of an episome produced in hamster cells that amplify a transfected CAD gene at high frequency: functional evidence for a mammalian replication origin. Mol Cell Biol 1987; 7: 1740–1750.
Wahl GM . The importance of circular DNA in mammalian gene amplification. Cancer Res 1989; 49: 1333–1340.
Ruiz JC, Wahl GM . Chromosomal destabilization during gene amplification. Mol Cell Biol 1990; 10: 3056–3060.
Baldini A, Ried T, Shridhar V, Ogura K, D'Aiuto L, Rocchi M et al. An alphoid DNA sequence conserved in all human and great ape chromosomes: evidence for ancient centromeric sequences at human chromosomal region 2q21 and 9q13. Hum Genet 1993; 90: 577–583.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ballerini, P., Busson, M., Fasola, S. et al. NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have a prognostic significance. Leukemia 19, 468–470 (2005). https://doi.org/10.1038/sj.leu.2403654
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403654
This article is cited by
-
Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia
Leukemia (2009)
-
Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies
Leukemia (2008)
-
Transition from EML1-ABL1 to NUP214-ABL1 positivity in a patient with acute T-lymphoblastic leukemia
Leukemia (2006)
-
Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast
Leukemia (2006)